Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Luger TA. Beissert S, et al. Among authors: rzany b. Arch Dermatol. 2006 Nov;142(11):1447-54. doi: 10.1001/archderm.142.11.1447. Arch Dermatol. 2006. PMID: 17116835 Clinical Trial.
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Bonsmann G, Luger TA. Beissert S, et al. Among authors: rzany b. Arch Dermatol. 2007 Dec;143(12):1536-42. doi: 10.1001/archderm.143.12.1536. Arch Dermatol. 2007. PMID: 18087004 Clinical Trial.
Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age.
Rzany B, Partscht K, Jung M, Kippes W, Mecking D, Baima B, Prudlo C, Pawelczyk B, Messmer EM, Schuhmann M, Sinkgraven R, Büchner L, Büdinger L, Pfeiffer C, Sticherling M, Hertl M, Kaiser HW, Meurer M, Zillikens D, Messer G. Rzany B, et al. Arch Dermatol. 2002 Jul;138(7):903-8. doi: 10.1001/archderm.138.7.903. Arch Dermatol. 2002. PMID: 12071817
European evidence-based (S3) guidelines for the treatment of acne.
Nast A, Dréno B, Bettoli V, Degitz K, Erdmann R, Finlay AY, Ganceviciene R, Haedersdal M, Layton A, López-Estebaranz JL, Ochsendorf F, Oprica C, Rosumeck S, Rzany B, Sammain A, Simonart T, Veien NK, Zivković MV, Zouboulis CC, Gollnick H; European Dermatology Forum. Nast A, et al. Among authors: rzany b. J Eur Acad Dermatol Venereol. 2012 Feb;26 Suppl 1:1-29. doi: 10.1111/j.1468-3083.2011.04374.x. J Eur Acad Dermatol Venereol. 2012. PMID: 22356611 No abstract available.
Efficacy and safety of methantheline bromide (Vagantin(®) ) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial.
Müller C, Berensmeier A, Hamm H, Dirschka T, Reich K, Fischer T, Rzany B. Müller C, et al. Among authors: rzany b. J Eur Acad Dermatol Venereol. 2013 Oct;27(10):1278-84. doi: 10.1111/j.1468-3083.2012.04708.x. Epub 2012 Sep 25. J Eur Acad Dermatol Venereol. 2013. PMID: 23004926 Clinical Trial.
187 results